jrnl5822

Publication Venue For

  • A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.  210:239-244. 2019
  • The transcriptome landscape associated with Disrupted-in-Schizophrenia-1 locus impairment in early development and adulthood.  210:149-156. 2019
  • Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.  204:262-270. 2019
  • Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia.  197:484-491. 2018
  • Substantia nigra ultrastructural pathology in schizophrenia.  197:209-218. 2018
  • Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.  182:66-73. 2017
  • Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.  177:78-87. 2016
  • A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.  170:341-350. 2016
  • Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.  169:369-373. 2015
  • Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.  168:543-553. 2015
  • Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.  166:219-224. 2015
  • UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment.  164:187-192. 2015
  • Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.  154:1-13. 2014
  • Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia.  154:36-41. 2014
  • Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex.  152:111-116. 2014
  • Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia.  159:130-135. 2014
  • Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia.  147:32-38. 2013
  • Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia.  146:177-183. 2013
  • Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.  144:1-8. 2013
  • Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.  140:136-142. 2012
  • Heritability of functioning in families with schizophrenia in relation to neurocognition.  139:105-109. 2012
  • Regional differences in expression of β-tubulin isoforms in schizophrenia.  135:181-186. 2012
  • Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.  131:52-57. 2011
  • Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.  130:260-265. 2011
  • Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.  119:198-209. 2010
  • Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.  117:92-98. 2010
  • Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.  114:50-56. 2009
  • Linkage analysis of schizophrenia in African-American families.  109:70-79. 2009
  • Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.  104:108-120. 2008
  • Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.  103:71-82. 2008
  • Diffusion tensor imaging in schizophrenia: Relationship to symptoms.  98:157-162. 2008
  • Disruption of hippocampal connectivity in children and adolescents with schizophrenia - A voxel-based diffusion tensor imaging study.  90:302-307. 2007
  • Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.  90:15-27. 2007
  • Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.  86:167-171. 2006
  • Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.  78:87-93. 2005
  • Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia.  75:27-34. 2005
  • NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder.  71:361-370. 2004
  • Thalamic dysfunction in schizophrenia: Neurochemical, neuropathological, and in vivo imaging abnormalities.  69:237-253. 2004
  • Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia.  68:65-73. 2004
  • Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia.  62:213-224. 2003
  • Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain.  38:7-12. 1999
  • Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.  33:113-118. 1998
  • The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia.  31:141-150. 1998
  • Clozapine-reserpine combination for refractory psychosis.  25:259-260. 1997
  • Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature.  22:133-141. 1996